Literature DB >> 3282533

Erythromycin enhances the absorption of cyclosporin.

S K Gupta1, A Bakran, R W Johnson, M Rowland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3282533      PMCID： PMC1386366          DOI： 10.1111/j.1365-2125.1988.tb03320.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Erythromycin and cyclosporine.

Authors:  T A Gonwa; D D Nghiem; J A Schulak; R J Corry
Journal:  Transplantation       Date:  1986-06       Impact factor: 4.939

2.  Interaction between cyclosporin and erythromycin in a kidney transplant patient.

Authors:  M Kessler; J Louis; E Renoult; B Vigneron; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.

Authors:  S K Gupta; B Legg; L R Solomon; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

4.  Cyclosporin-phenytoin interaction: re-evaluation using metabolite data.

Authors:  M Rowland; S K Gupta
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

5.  Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites.

Authors:  D J Freeman; A Laupacis; P A Keown; C R Stiller; S G Carruthers
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335
  5 in total
  14 in total

1.  Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures.

Authors:  K Mohri; Y Uesawa
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

Review 2.  Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.

Authors:  J F Westphal
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

3.  The effects of spiramycin on plasma cyclosporin A concentrations in heart transplant patients.

Authors:  R Guillemain; E Billaud; G Dreyfus; C Amrein; M Kitzis; V A Jebara; C Kreft-Jais
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Loss of orally administered drugs in GI tract.

Authors:  Yogeshkumar Nanasaheb Gavhane; Adhikrao Vyankatrao Yadav
Journal:  Saudi Pharm J       Date:  2012-04-20       Impact factor: 4.330

Review 5.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 6.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

7.  Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction.

Authors:  M F Fromm; K Dilger; D Busse; H K Kroemer; M Eichelbaum; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

Review 8.  Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.

Authors:  Marie Lund; Tonny Studsgaard Petersen; Kim Peder Dalhoff
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

9.  Interaction between roxithromycin and cyclosporin in heart transplant patients.

Authors:  E M Billaud; R Guillemain; N Fortineau; M D Kitzis; G Dreyfus; C Amrein; C Kreft-Jaïs; J M Husson; P Chrétien
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

10.  The cyclosporin-erythromycin interaction: impaired first pass metabolism in the pig.

Authors:  D J Freeman; D R Grant; S G Carruthers
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.